Some Practical Issues in the Antenatal Detection of Neural Tube Defects and Down’s Syndrome
Maternal serum alphafetoprotein (AFP) and ultrasound screening for neural tube defects is now established in Britain and recently serum screening for Down’s syndrome has been introduced in a number of centres. Our purpose in this chapter is not to review the subject as a whole but to identify some practical issues that perhaps need wider recognition.
KeywordsUrea Progesterone Acetylcholinesterase Dehydroepiandrosterone Oestriol
Unable to display preview. Download preview PDF.
- 2.Cuckle HS, Nanchahal K, Wald NJ. Birth prevalence of Down’s syndrome in England and Wales. Prenat Diagn, in press.Google Scholar
- 5.Wald NJ, Cuckle HS, Haddow JE, Doherty RA, Knight GJ, Palomaki GE. The ultrasonographic diagnosis of open spina bifida. N Engl J Med, in press.Google Scholar